Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial
Gurevich, Irina, Agarwal, Pooja, Zhang, PeiPei, Dolorito, John A., Oliver, Stacie, Liu, Henry, Reitze, Nicholas, Sarma, Nikhil, Bagci, Isin Sinem, Sridhar, Kunju, Kakarla, Visesha, Yenamandra, Vamsi K., O’Malley, Mark, Prisco, Marco, Tufa, Sara F., Keene, Douglas R., South, Andrew P., Krishnan, Suma M., Marinkovich, M. Peter
Published in Nature medicine (01.04.2022)
Published in Nature medicine (01.04.2022)
Get full text
Journal Article
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa
Marinkovich, M. Peter, Paller, Amy S., Guide, Shireen V., Gonzalez, Mercedes E., Lucky, Anne W., Bağcı, Işın Sinem, Agostini, Brittani, Fitzgerald, Kolleen, Chen, Shijie, Chen, Hubert, Conner, Meghan M., Krishnan, Suma M.
Published in American journal of clinical dermatology (01.07.2025)
Published in American journal of clinical dermatology (01.07.2025)
Get full text
Journal Article
Correction to: Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa
Marinkovich, M. Peter, Paller, Amy S., Guide, Shireen V., Gonzalez, Mercedes E., Lucky, Anne W., Bağcı, Işın Sinem, Agostini, Brittani, Fitzgerald, Kolleen, Chen, Shijie, Chen, Hubert, Conner, Meghan M., Krishnan, Suma M.
Published in American journal of clinical dermatology (01.07.2025)
Published in American journal of clinical dermatology (01.07.2025)
Get full text
Journal Article
Efficacy and Safety of the Topical Gene Therapy Beremagene Geperpavec‐ svdt (B‐VEC) in an Open‐Label Study of Japanese Subjects With Dystrophic Epidermolysis Bullosa
Natsuga, Ken, Tsuruta, Daisuke, Takashima, Shota, Tateishi, Chiharu, Takatoku, Masaaki, Agostini, Brittani, Mailliard, Sarrah, Reitze, Nicholas J., Beacham, Rebecca T., Cardiges, Alexia M., Johnston, Michael J., Edukulla, Ramakrishna, Krishnan, Suma M.
Published in Journal of dermatology (16.07.2025)
Published in Journal of dermatology (16.07.2025)
Get full text
Journal Article
Abstract 7260: An HSV-1-based vector for local delivery of IL-12 and IL-2 reshapes the immune landscape leading to tumor clearance and systemic immune surveillance
Previte, Dana M., Parry, Trevor J., Krishnan, Suma M.
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa: Long-Term Safety and Tolerability of B-VEC in an OLE Study of Patients with DEB
Marinkovich, M. Peter, Paller, Amy S., Guide, Shireen V., Gonzalez, Mercedes E., Lucky, Anne W., Bağcı, Işın Sinem, Agostini, Brittani, Fitzgerald, Kolleen, Chen, Shijie, Chen, Hubert, Conner, Meghan M., Krishnan, Suma M.
Published in American journal of clinical dermatology (01.07.2025)
Published in American journal of clinical dermatology (01.07.2025)
Get full text
Journal Article
Correction to: Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa: Correction to: Long-Term Safety and Tolerability of B-VEC in an OLE Study of Patients with DEB
Marinkovich, M. Peter, Paller, Amy S., Guide, Shireen V., Gonzalez, Mercedes E., Lucky, Anne W., Bağcı, Işın Sinem, Agostini, Brittani, Fitzgerald, Kolleen, Chen, Shijie, Chen, Hubert, Conner, Meghan M., Krishnan, Suma M.
Published in American journal of clinical dermatology (01.07.2025)
Published in American journal of clinical dermatology (01.07.2025)
Get full text
Journal Article
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
Biederman, Joseph, Krishnan, Suma, Zhang, Yuxin, McGough, James J., Findling, Robert L.
Published in Clinical therapeutics (01.03.2007)
Published in Clinical therapeutics (01.03.2007)
Get full text
Journal Article
Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: A single-dose, randomized, open-label, crossover study
Boellner, Samuel W., Stark, Jeffrey G., Krishnan, Suma, Zhang, Yuxin
Published in Clinical therapeutics (01.02.2010)
Published in Clinical therapeutics (01.02.2010)
Get full text
Journal Article